Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer

Objective. Caveolin-1 (Cav-1), as the main component of caveolae, has complex roles in tumourigenesis in human malignancies. We investigated Cav-1 in primary and metastatic tumor cells of gastric cancer (GC) and its association with clinical outcomes. Methods. We retrieved 145 cases of GC who had un...

Full description

Saved in:
Bibliographic Details
Main Authors: Der Sheng Sun, Soon Auck Hong, Hye Sung Won, Su Hyun Yoo, Han Hong Lee, Okran Kim, Yoon Ho Ko
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2017/5905173
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567961337987072
author Der Sheng Sun
Soon Auck Hong
Hye Sung Won
Su Hyun Yoo
Han Hong Lee
Okran Kim
Yoon Ho Ko
author_facet Der Sheng Sun
Soon Auck Hong
Hye Sung Won
Su Hyun Yoo
Han Hong Lee
Okran Kim
Yoon Ho Ko
author_sort Der Sheng Sun
collection DOAJ
description Objective. Caveolin-1 (Cav-1), as the main component of caveolae, has complex roles in tumourigenesis in human malignancies. We investigated Cav-1 in primary and metastatic tumor cells of gastric cancer (GC) and its association with clinical outcomes. Methods. We retrieved 145 cases of GC who had undergone curative gastrectomy. The expression levels of Cav-1 was evaluated by immunohistochemistry, and its association with clinicopathological parameters and patient survival was analyzed. Results. High expression of Cav-1 protein of the GC in the stomach and metastatic lymph node was 12.4% (18/145) and 16.5% (15/91). In the multivariate analysis, tumoral Cav-1 protein in metastatic lymph node showed prognostic significance for relapse-free survival (RFS, HR, 3.934; 95% CI, 1.882–8.224; P=0.001) and cancer-specific survival outcome (CSS, HR, 2.681; 95% CI, 1.613–8.623; P=0.002). Among the GCs with metastatic lymph node, it remained as a strong indicator of poor prognosis for RFS (HR, 3.136; 95% CI, 1.444–6.810; P=0.004) and CSS (HR, 2.509; 95% CI, 1.078–5.837; P=0.032). Conclusion. High expression of tumoral Cav-1 protein in metastatic lymph node is associated with unfavorable prognosis of curative resected GC, indicating the potential of novel prognostic markers.
format Article
id doaj-art-c185956938134dacaba4602ef10f4511
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-c185956938134dacaba4602ef10f45112025-02-03T01:00:02ZengWileyGastroenterology Research and Practice1687-61211687-630X2017-01-01201710.1155/2017/59051735905173Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric CancerDer Sheng Sun0Soon Auck Hong1Hye Sung Won2Su Hyun Yoo3Han Hong Lee4Okran Kim5Yoon Ho Ko6Division of Oncology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of KoreaDepartment of Pathology, Soonchunhyang Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Republic of KoreaDivision of Oncology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of KoreaDepartment of Hospital Pathology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu-si, Republic of KoreaDepartment of General Surgery, The Catholic University of Korea, Seoul, Republic of KoreaCancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaDivision of Oncology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of KoreaObjective. Caveolin-1 (Cav-1), as the main component of caveolae, has complex roles in tumourigenesis in human malignancies. We investigated Cav-1 in primary and metastatic tumor cells of gastric cancer (GC) and its association with clinical outcomes. Methods. We retrieved 145 cases of GC who had undergone curative gastrectomy. The expression levels of Cav-1 was evaluated by immunohistochemistry, and its association with clinicopathological parameters and patient survival was analyzed. Results. High expression of Cav-1 protein of the GC in the stomach and metastatic lymph node was 12.4% (18/145) and 16.5% (15/91). In the multivariate analysis, tumoral Cav-1 protein in metastatic lymph node showed prognostic significance for relapse-free survival (RFS, HR, 3.934; 95% CI, 1.882–8.224; P=0.001) and cancer-specific survival outcome (CSS, HR, 2.681; 95% CI, 1.613–8.623; P=0.002). Among the GCs with metastatic lymph node, it remained as a strong indicator of poor prognosis for RFS (HR, 3.136; 95% CI, 1.444–6.810; P=0.004) and CSS (HR, 2.509; 95% CI, 1.078–5.837; P=0.032). Conclusion. High expression of tumoral Cav-1 protein in metastatic lymph node is associated with unfavorable prognosis of curative resected GC, indicating the potential of novel prognostic markers.http://dx.doi.org/10.1155/2017/5905173
spellingShingle Der Sheng Sun
Soon Auck Hong
Hye Sung Won
Su Hyun Yoo
Han Hong Lee
Okran Kim
Yoon Ho Ko
Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
Gastroenterology Research and Practice
title Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
title_full Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
title_fullStr Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
title_full_unstemmed Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
title_short Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
title_sort prognostic value of metastatic tumoral caveolin 1 expression in patients with resected gastric cancer
url http://dx.doi.org/10.1155/2017/5905173
work_keys_str_mv AT dershengsun prognosticvalueofmetastatictumoralcaveolin1expressioninpatientswithresectedgastriccancer
AT soonauckhong prognosticvalueofmetastatictumoralcaveolin1expressioninpatientswithresectedgastriccancer
AT hyesungwon prognosticvalueofmetastatictumoralcaveolin1expressioninpatientswithresectedgastriccancer
AT suhyunyoo prognosticvalueofmetastatictumoralcaveolin1expressioninpatientswithresectedgastriccancer
AT hanhonglee prognosticvalueofmetastatictumoralcaveolin1expressioninpatientswithresectedgastriccancer
AT okrankim prognosticvalueofmetastatictumoralcaveolin1expressioninpatientswithresectedgastriccancer
AT yoonhoko prognosticvalueofmetastatictumoralcaveolin1expressioninpatientswithresectedgastriccancer